More NewsRead More
Idera Presents Preclinical Data Demonstrating Enhanced Systemic Anti-Tumor Activity from Combination Treatment with Intra-tumoral IMO-2125 and IDO-1 Inhibitor at AACR Annual Meeting 2016
April 19, 2016
Idera Pharmaceuticals Reports Fourth Quarter and Year End 2015 Financial Results and Provides Corporate Update
March 10, 2016
Propanc Health Group, Top Our List for Investor Potential in Biotech
February 12, 2016
category Banking & Financial Services
Biotechnology Stocks Review -- Idera Pharma, Vital Therapies, Lion Biotechnologies, and Cara Therapeutics
January 08, 2016
category Publishing & Media
18 Biotechnology Stocks to Sell Now
June 06, 2016
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here